- Home
- MRNS vs LGL Comparison
MRNS vs LGL Comparison
Compare MRNS & LGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRNS
- LGL
- Stock Information
- Founded
- MRNS 2003
- LGL 1917
- Country
- MRNS United States
- LGL United States
- Employees
- MRNS N/A
- LGL N/A
- Industry
- MRNS Biotechnology: Pharmaceutical Preparations
- LGL Industrial Machinery/Components
- Sector
- MRNS Health Care
- LGL Technology
- Exchange
- MRNS Nasdaq
- LGL Nasdaq
- Market Cap
- MRNS 29.9M
- LGL 31.5M
- IPO Year
- MRNS 2014
- LGL N/A
- Fundamental
- Price
- MRNS $0.54
- LGL $6.55
- Analyst Decision
- MRNS Buy
- LGL
- Analyst Count
- MRNS 12
- LGL 0
- Target Price
- MRNS $4.28
- LGL N/A
- AVG Volume (30 Days)
- MRNS 3.2M
- LGL 9.0K
- Earning Date
- MRNS 03-04-2025
- LGL 11-13-2024
- Dividend Yield
- MRNS N/A
- LGL N/A
- EPS Growth
- MRNS N/A
- LGL 66.76
- EPS
- MRNS N/A
- LGL 0.07
- Revenue
- MRNS $31,466,000.00
- LGL $4,130,000.00
- Revenue This Year
- MRNS $14.97
- LGL N/A
- Revenue Next Year
- MRNS $57.65
- LGL N/A
- P/E Ratio
- MRNS N/A
- LGL $96.32
- Revenue Growth
- MRNS 1.63
- LGL 26.49
- 52 Week Low
- MRNS $0.22
- LGL $4.86
- 52 Week High
- MRNS $10.50
- LGL $6.80
- Technical
- Relative Strength Index (RSI)
- MRNS 70.29
- LGL 58.54
- Support Level
- MRNS $0.54
- LGL $6.15
- Resistance Level
- MRNS $0.56
- LGL $6.68
- Average True Range (ATR)
- MRNS 0.02
- LGL 0.27
- MACD
- MRNS 0.01
- LGL 0.05
- Stochastic Oscillator
- MRNS 93.71
- LGL 76.19
About MRNS Marinus Pharmaceuticals Inc.
Marinus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing innovative therapeutics to treat epilepsy and neuropsychiatric disorders. Marinus manages the business in one segment, which is the identification and development of neuropsychiatric therapeutics. The Company is developing ganaxolone for multiple epilepsy and other neuropsychiatric indications, including adjunctive, or add-on, therapy for the treatment of drug-resistant focal onset seizures; status epilepticus; Fragile X Syndrome, and PCDH19-RE.
About LGL LGL Group Inc. (The)
LGL Group Inc is a holding company engaged in services, merchant investment and manufacturing business activities. The company has two reportable segments; Electronic Instruments and Merchant Investment. The Electronic Instruments segment, which generates key revenue, is focused on designing and manufacturing high-performance Frequency and Time reference standards that form the basis for timing and synchronization in various applications including satellite communication, time transfer systems, network synchronization, electricity distribution, and metrology. The Merchant Investment segment comprises various investment vehicles in which the company invests its capital.